Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380A

Toxicology Letters

Volumn 192, Issue 3, 2010, Pages 373-378

  Arnal, Nathalie ^a   de Alaniz, María J T ^a   Marra, Carlos A ^a  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

Author keywords

Copper; Enzyme activities; IUD; Liver; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; CERULOPLASMIN; COPPER INTRAUTERINE DEVICE; GLUTATHIONE; METALLOTHIONEIN; NITRATE; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CERULOPLASMIN; COPPER; FEMALE; GLUTATHIONE; HOMEOSTASIS; HUMANS; INTRAUTERINE DEVICES, COPPER; METALLOTHIONEIN; NITRATES; NITRITES; OXIDATIVE STRESS;

EID: 75549087496     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.11.012     Document Type: Article

References (56)

1. Abuja M., and Albertini R. Methods for monitorin oxidative stress, lipid peroxidation and oxidation resistence of lipoproteins. Clin. Chim. Acta 1-2 (2001) 1-17
2. Amla S., Gupta I., Kausalva S., and Ganguly N.K. Active oxygen species in copper intrauterine device users. Contraception 48 (1993) 150-156
3. Anderson M.E., and Meister A. Enzymatic assay of GSSG plus GSH. Meth. Enzymol. 105 (1984) 448-450
4. Aston N.S., Watt N., Morton I.E., Tanner M.S., and Evans G.S. Copper toxicity affects proliferation and viability of human hepatoma cells (HepG2 line). Hum. Exp. Toxicol. 19 (2000) 367-376
5. Balamurugan K., and Schaffner W. Copper homeostasis in eukaryotes: teetering on a tightrope. Biochim. Biophys. Acta 1763 (2006) 737-746
6. Beltrán-García M.J., Espinosa A., Herrera N., Perez-Zapata A.J., Beltrán-García C., and Ogura T. Formation of copper oxychloride and reactive oxygen species as causes of uterine injury during copper oxidation of Cu-IUD. Contraception 61 (2000) 99-103
7. Benzie I.F.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "Antioxidant power": the FRAP assay. Anal. Biochem. 239 (1996) 70-76
8. Berkovitch M., Heyman E., Afriat R., Matz-Khromchenko I., Avgil M., Greenberg R., Zimmerman D.R., Berman S., and Weissgarten J. Copper and zinc blood levels among children with nonorganic failure to thrive. Clin. Nutr. 22 (2003) 183-186
9. Bienengrabër M., Fordekunz S., Klein D., and Summer K.H. Determination of Cu-containing metallothionein: comparison of Ag saturation assat, thiomolybdate assay, and enzyme-linked immunosorbent assay. Anal. Biochem. 228 (1995) 69-73
10. Blalock T.L., Dunn M.A., and Cousins R.J. Metallothionein gene expression in rats: tissue-specific regulation by dietary copper and zinc. J. Nutr. 118 (1987) 222-228
11. Broadley C., and Hoover R.L. Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells. Am. J. Pathol. 135 (1989) 647-655
12. Bush A. The methallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003) 207-214
13. Calderón J., Ortiz-Pérez D., Yáñez L., and Díaz-Barriga F. Human exposure to metals. Pathways of exposure, biomarkers of effect and host factors. Ecotox. Environ. Saf. 56 (2003) 93-103
14. Cerón J.J., and Martínez-Subiela S. An automated spectrophotometric method for measuring canine ceruloplasmin in serum. Vet. Res. 35 (2004) 671-679
15. Chung K.Y., Lee S.J., Chung S.M., Lee M.Y., Bae O.N., and Chung J.H. Generation of free radical by interaction of iron with thiols in human plasma and its possible significance. Thromb. Res. 116 (2005) 157-164
16. Coyle P., Philcox J.C., Carey L.C., and Rofe A.M. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 59 (2002) 627-647
17. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., and Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329 (2003) 23-38
18. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., and Milzani A. Protein carbonylation in human diseases. Trends Mol. Med. 9 (2003) 169-176
19. De la Cruz D., Cruz A., Arteaga M., Castillo L., and Tovalin H. Blood copper levels in Mexican users of the T380A IUD. Contraception 72 (2005) 122-125
20. Egli D., Yepiskoposyan H., Selvaraj A., Balamurugan K., Rajaram R., Simons A., Multhaup G., Mettler S., Vardanyan A., Georgiev O., and Schaffner W. A family knockout of all four Drosophila metallothioneins reveals a central role in copper homeostasis and detoxification. Mol. Cell Biol. 26 (2006) 2286-2296
21. Emerit J., Edeas M., and Bricaire F. Neurodegenerative diseases and oxidative stress. Biochem. Pharmacol. 58 (2004) 39-46
22. Facheris M., Beretta S., and Ferrarese C. Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy?. J. Alzheimers Dis. 6 (2004) 177-184
23. Fahmy K., Ghoneim M., Eisa I., El-Gazar A., and Afifi A. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs. Contraception 47 (1993) 483-490
24. Gaetke L.M., and Chow C.K. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189 (2003) 147-163
25. Geetha A., Jeyachristy S.A., Selvamathy S.M., Ilavarasi S., and Surendran R. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease. Clin. Chim. Acta 383 (2007) 165-167
26. Hayashi T., Shishido N., Nakayama K., Nunomura A., Smith M.A., Perry G., and Nakamura M. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide. Free Radic. Biol. Med. 43 (2007) 1552-1559
27. Hefnawi F., Kandil O., Askalani H., Zaki K., Nasr F., and Mousa M. Copper levels in women using intrauterine devices or oral contraceptives. Fertil. Steril. 25 (1974) 556-561
28. Hultberg B., Andersson A., and Isaksson A. Copper ions differ from other thiol reactive metal ions in their effects on the concentration and redox status of thiols in HeLa cell cultures. Toxicology 117 (1997) 89-97
29. Karten B., Beisiegel U., Gercken G., and Kontush A. Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach. Chem. Phys. Lip. 88 (1997) 83-96
30. Kelimbaum, D.G, Kupper, L.L., 1997. In: Applied regression analysis and other multivariable methods. 3rd ed. Pacific Grove, CA, Duxbury Press, London, UK.
31. Kjaer A., Laursen K., Thormann L., Borggaard O., and Lebech P.E. Copper release from copper intrauterine devices removed after up to 8 years of use. Contraception 47 (1993) 349-358
32. Krumschnabe L.G., Manzl C., Berger C., and Hofer B. Oxidative stress, mitochondrial permeability transition, and cell death in Cu-exposed trout hepatocytes. Toxicol. Appl. Pharm. 209 (2005) 62-73
33. Linder M.C. Copper and genomic stability in mammals. Mutat. Res.-Fund. Mol. Mech. Mut. 475 (2001) 141-152
34. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
35. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62-71
36. Penney G. Contraception in adolescence. Women's Health Med. 2 (2005) 19-21
37. Pincemail J., Vanbelle S., Gaspard U., Collette G., Haleng J., Cheramy-Bien J.P., Charlier C., Chapelle J.P., Giet D., Albert A., Limet R., and Defraigne J.O. Effect of different contraceptive methods on the oxidative stress status in women aged 40-48 years from the ELAN study in the province of Liége, Belgium. Hum. Reprod. 8 (2007) 2335-2343
38. Pradhan M., Gupta I., and Ganguli N.K. Nitrites and L-citruline levels in copper intrauterine device users. Contraception 55 (1997) 315-318
39. Prakasam A., Sethupathy S., and Lalitha S. Plasma and RBCs antioxidant status in occupational male pesticide sprayers. Clin. Chim. Acta 310 (2001) 107-112
40. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth. Enzymol. 233 (1994) 357-363
41. Roblero L., Guadarrama A., Lopez T., and Zegers-Hochschild F. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod. Fertil. Dev. 8 (1996) 871-874
42. Scheuhammer A.M., and Cherian M.G. Quantification of metallothionein by a silver-saturation method. Toxicol. Appl. Pharmacol. 15 (1986) 417-425
43. Selvaraj A., Balamurugan K., Yepiskoposyan H., Zhou H., Egli D., Georgiev O., Thiele D.J., and Schaffner W. Metal-responsive transcription factor (MTF-1) handles both extremes, copper load and copper starvation, by activating different genes. Genes Dev. 19 (2005) 891-896
44. Sivin I. Utility and drawbacks of continuous use of copper T IUD for 20 years. Contraception 75 (2007) 70-75
45. Snyder R., and Friedman M. Enhancement of cytotoxicity and clastogenicity of L-DOPA and dopamine by manganese and copper. Mut. Res. 405 (1998) 1-8
46. Squitti R., Pasqualetti P., Cassetta E., Dal Forno G., Cesaretti S., Pedace F., Finazzi-Agrò A., and Rossini P.M. Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia. Neurology 60 (2003) 2013-2014
47. Strausak D., Mercer J.F., Dieter H.H., Stremmel W., and Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res. Bull. 55 (2001) 175-185
48. Tapiero, Townsend D.M., and Tew K.D. Trace elements in human physiology and pathology. Copper Biomed. Pharmacother. 57 (2003) 386-398
49. Terrés-Martos C., Navarro-Alarcón M., Martín-Lagos F., López G., De la Serrana H., and López-Martínez M.C. Determination of copper levels in serum of healthy subjects by atomic absorption spectrometry. Sci. Total Environ. 198 (1997) 97-103
50. Thomas T., Macpherson A., and Rogers P. Ceruloplasmin gene expression in the rat uterus. Biochim. Biophys. Acta 1261 (1995) 77-82
51. Tokokuni S., and Sagripanti J.L. Increased 8-hydroxydeoxyguanosine in kidney and liver of rats continuously exposed to copper. Toxicol. Appl. Phamacol. 126 (1994) 91-97
52. Twomey P.J., Wierzbicki A.S., House I.M., Viljoen A., and Reynolds T.M. Percentage non-ceruloplasmin bound copper. Clin. Biochem. 40 (2007) 749-750
53. Waggoner D.J., Bartnikas T.B., and Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 6 (1999) 221-230
54. WHO. Farley, T.M.M., Meirik, O., Rowe, P.J., 1999. Safety and efficacy of existing methods of fertility regulation. In: WHO, Reprod. Health Res. Ann. Techcnical Report.
55. Yagi K. A simple flourometric assay for lipoperoxides in blood plasma. Biochem. Med. 15 (1976) 212-216
56. Zelazowski A.J., Gasyna Z., and Stillman M.J. Silver binding to rabbit liver metallothionein. J. Biol. Chem. 264 (1989) 17091-17099